January 26, 2009
India and China have become the dominant and sometimes sole suppliers of pharmaceutical ingredients and other raw materials for life-saving medicines used by patients in the United States and other rich countries. Some U.S. experts are calling for a law requiring that certain drugs be made or stockpiled in the United States. Ruth Levine, CGD vice president for programs and operations, argues for stronger multilateral collaboration instead.